Aridis Pharmaceuticals Inc. Common Stock (ARDS)

ARDS was delisted on the 18th of July, 2023.

• Market cap: $11.2M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Employees: 37